https://www.selleckchem.com/pr....oducts/nmda-n-methyl
It is vital that their providers understand the frequency of these concerns as well as patients' preference for intervention. While HCT has become increasingly successful in treating hematologic cancers, many survivors experience a range of issues post-transplant. Survivorship care for these patients must include ongoing thorough assessment related to the practical, emotional, and medical symptoms experienced post-transplant, with appropriate intervention provided in-house where possible or in the community accordi